Dr María Cristina Ovejero - Boglione

Dr María Cristina Ovejero-Boglione is a highly experienced medical professional with a diverse background in research, teaching, and consultancy roles. Dr María Cristina'swork experience includes:

- At Zintro Inc, they served as an Expert/Consultant in Medical Technologies, Nanotgenetics, and Quantum Nanoscience. Dr María Cristina provided advice on the formulation of medicinal supplements, focusing on eliminating risks and improving efficacy.

- As a Clinical Researcher at 7 Universal Principles, Dr Ovejero-Boglione specialized in natural supplements and equipments for the treatment of resistant and incurable diseases. Dr María Cristina was also involved in the establishment of a Natural Regenerative Medicine Clinic for Research.

- Dr María Cristina worked as a Medical and Scientific Author for Writers and Authors, composing literature across various genres, including medical and scientific topics. Dr María Cristina'swork consisted of short articles for magazines and book chapters based on factual scientific evidence.

- At the University of West London, Dr Ovejero-Boglione held multiple role titles. Dr María Cristina was the Pharmacology Module Leader, responsible for teaching university students about legal pharmacological drugs, drug interactions, toxicology, and clinical research. Dr María Cristina also served as the Module Leader for Drugs of Abuse, educating students about the effects and dangers of medical, legal, and illegal drugs. Additionally, they were the Module Leader of Research Methods in Science, teaching students about research design, methodology, and scientific writing.

- During their time at King's College London, they worked as a Medical Research Associate, In Vivo Neurosurgeon, and Biochemistry Tutor. Dr María Cristina'sresearch focused on optic pathway regeneration and the effects of glial cells on neuronal regeneration and axon growth.

- At Spinal Research, Dr Ovejero-Boglione worked as a Medical Researcher, investigating brain and spinal cord regeneration using molecules within cells and the extracellular matrix. Dr María Cristina attended international meetings on translational research and clinical trials.

- Dr María Cristina also worked as a Medical Products and Biotechnology Consultant at Accenture, providing guidance and expertise in these fields.

- Dr Ovejero-Boglione is the Founder, Secretary, and Director of APARU (Asociación de Profesionales Argentinos en Reino Unido), a charitable organization supporting Argentine NGO-led projects. Dr María Cristina played a key leadership role in various teams and prepared registration documents for submission to The Charity Commission for England and Wales.

- Lastly, they worked as a Medical Research Associate at Imperial College London, conducting medical neuroscience research in vivo and supervising research assistants.

Overall, Dr María Cristina Ovejero-Boglione has a strong background in medical research, teaching, and consultancy, with expertise in various areas such as medical technologies, regenerative medicine, pharmacology, and neuroscience.

Dr. María Cristina Ovejero - Boglione has an extensive education history. Dr María Cristina began their education at Colegio Alemán Johann Goethe (Goethe Schule Rosario) from 1976 to 1987, where they completed their primary and initial secondary education focusing on Spanish and German studies. In 1991, they attended Universidad Nacional de Rosario and obtained their MD, specializing in pre-clinical medicine. Continuing their education, they enrolled at the University of Bristol in 1996, where they pursued higher education in Information Technology, focusing on Microsoft Packages and programming in C++. From 1999 to 2002, they attended the University of the West of England and earned a BSc (Hons) in Biochemistry and Molecular Biology. In 2003, Dr. Ovejero - Boglione joined Imperial College London, collaborating with King's College London, and received a Master of Philosophy (MPhil), which progressed into their subsequent PhD in Physiology - Tissue Regeneration, specifically in the field of brain and spinal cord regeneration, which they completed in 2008 at King's College London.